A new research has shown the possibility of tackling treatment-resistant depression by treating patients for possible metabolic deficiencies. The results showed an improvement in symptoms and even remission in some cases.
The research conducted by University of Pittsburgh’s School of Medicine was published Friday in the American Journal of Psychiatry.
“What’s really promising about these new findings is that they indicate that there may be physiological mechanisms underlying depression that we can use to improve the quality of life in patients with this disabling illness,” said Dr. David Lewis, from Pitt’s Department of Psychiatry in a press release.
According to lead study investigator Dr. Lisa Pan, of the almost 15 million American adults that suffer from depression, or major depressive disorder, at least 15 percent do not find relief from conventional treatments like psychotherapy and antidepressant medications.